Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

Delayed Quote. Delayed Nasdaq - 01/30 04:00:04 pm
183.24 USD   -2.56%
01/29DJAlexion Pharmaceuticals Promotes COO to CEO Post
01/29 ALEXION PHARMAC : BRIEF: Alexion Hires BioXcel Data Analysis Firm to..
01/29 ALEXION PHARMAC : Names New CEO
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
182.76(c) 180.36(c) 177.78(c) 188.05(c) 183.24(c) Last
799 983 783 132 1 570 026 3 015 202 2 049 502 Volume
-0.31% -1.31% -1.43% +5.78% -2.56% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
01/29Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 2 679 M
EBIT 2015 1 340 M
Net income 2015 942 M
Finance 2015 2 840 M
Yield 2015 -
Sales 2016 3 329 M
EBIT 2016 1 742 M
Net income 2016 1 244 M
Finance 2016 4 290 M
Yield 2016 -
PER 2015 40,55
PER 2016 31,07
EV / Sales 2015 12,9x
EV / Sales 2016 9,91x
Capitalization 37 288 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
01:28a ALEXION PHARMACEUTICALS : Patented Medicine Prices Review Board Sets Public Hear..
01/29DJAlexion Pharmaceuticals Promotes COO to CEO Post
01/29 ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Change ..
01/29 ALEXION PHARMACEUTICALS : BRIEF: Alexion Hires BioXcel Data Analysis Firm to Hel..
01/29 ALEXION PHARMACEUTICALS : Names New CEO
01/29 ALEXION PHARMACEUTICALS : beats Street 4Q forecasts
01/29 ALEXION PHARMACEUTICALS : Appoints David L. Hallal as Chief Executive Officer, E..
01/29 ALEXION PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2014 Results and ..
More news
Sector news Biopharmaceuticals
06:43pDJMARKET SNAPSHOT : Gasoline 'Tax Cut' In Focus On Energy, Consumer-based Earnings
06:36pDJShire Drug Cleared to Treat Binge-Eating Disorder
04:17pDJAbbVie Hepatitis C Drug Predictions Disappoint -- Update
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF